Previous studies on Nectin-1 have concentrated on its role in sensitivity to herpes oncolytic therapy in squamous cell carcinoma, thyroid cancer and head/neck carcinoma [20]–[21]. Here, NECTIN1 is linked to thyroid gland carcinoma.